Biopol Chemicals IPO — Listing Performance
Biopol Chemicals had a flat debut, closing within 2.31% of its issue price, on strong subscription of 22.26x.
Biopol Chemicals IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 06-Feb-2026 |
| Listing date | 13-Feb-2026 |
| Issue size | ₹29.63 crore |
| Overall subscription | 22.26x |
| Issue price | ₹108 |
| Listing-day close | ₹105.50 (-2.31%) |
| Recent market price | ₹94.45 (-12.55% vs issue) |
| 52-week range | ₹84.75 – ₹133.75 |
| Identifiers | NSE: BIOPOL · ISIN: INE0XW001014 |
Figures are compiled from public market data and refreshed when our dataset updates. Verify against BSE/NSE records before acting on them.
How the listing went
Biopol Chemicals opened for subscription on 06-Feb-2026 as a SME issue raising about ₹30 crore. The shares were priced at ₹108 and made their debut on 13-Feb-2026, closing the first session at ₹105.50 — a listing-day change of -2.31%.
As of our last data refresh the stock trades around ₹94.45, 12.55% below the issue price. A listing-day gain does not guarantee lasting returns — and vice versa.
Every IPO in our archive gets this same treatment: real issue data, the actual listing-day result, and where the price stands now — so you can judge how debut hype translated into outcomes. Compare more debuts on the IPO listing-performance archive or check live grey-market sentiment on the GMP board.
Biopol Chemicals IPO FAQs
What was the Biopol Chemicals IPO listing price?
Biopol Chemicals closed at ₹105.50 on its listing day (13-Feb-2026), against an issue price of ₹108 — a listing-day change of -2.31%.
How many times was the Biopol Chemicals IPO subscribed?
The issue was subscribed about 22.26 times overall.
Was the Biopol Chemicals IPO profitable for allottees?
Not on listing day: the stock closed about 2.31% below the issue price. Longer-term outcomes depend on when shares were sold.